The University of Chicago Header Logo

Connection

Robert Wollmann to Myasthenia Gravis

This is a "connection" page, showing publications Robert Wollmann has written about Myasthenia Gravis.
Connection Strength

1.091
  1. Exome sequencing detection of two untranslated GFPT1 mutations in a family with limb-girdle myasthenia. Clin Genet. 2014 Feb; 85(2):166-71.
    View in: PubMed
    Score: 0.415
  2. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci. 1997 Jun 01; 17(11):4170-9.
    View in: PubMed
    Score: 0.139
  3. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Arch Neurol. 2012 Apr; 69(4):453-60.
    View in: PubMed
    Score: 0.095
  4. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 1991 Sep; 41(9):1497-504.
    View in: PubMed
    Score: 0.093
  5. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol. 1990 Nov; 82(2):284-8.
    View in: PubMed
    Score: 0.088
  6. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane. J Immunol. 1987 May 15; 138(10):3269-75.
    View in: PubMed
    Score: 0.069
  7. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci. 1998 May 13; 841:167-80.
    View in: PubMed
    Score: 0.037
  8. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. J Neuroimmunol. 1998 Jan; 81(1-2):98-108.
    View in: PubMed
    Score: 0.036
  9. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann Neurol. 1993 Jul; 34(1):48-56.
    View in: PubMed
    Score: 0.026
  10. Effector mechanisms of myasthenic antibodies. Ann N Y Acad Sci. 1993 Jun 21; 681:264-73.
    View in: PubMed
    Score: 0.026
  11. The hu-SCID myasthenic mouse. A new tool for the investigation of seronegative myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21; 681:303-5.
    View in: PubMed
    Score: 0.026
  12. The beta 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG). Int J Immunopharmacol. 1993 Jan; 15(1):19-24.
    View in: PubMed
    Score: 0.026
  13. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathol. 1984; 63(2):131-43.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.